BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20061053)

  • 1. Efficacy and safety of mycophenolate mofetil for lichen planopilaris.
    Cho BK; Sah D; Chwalek J; Roseborough I; Ochoa B; Chiang C; Price VH
    J Am Acad Dermatol; 2010 Mar; 62(3):393-7. PubMed ID: 20061053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lichen planopilaris with mycophenolate mofetil.
    Tursen U; Api H; Kaya T; Ikizoglu G
    Dermatol Online J; 2004 Jul; 10(1):24. PubMed ID: 15347506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of systemic mycophenolate mofetil with topical clobetasol in lichen planopilaris: a parallel-group, assessor- and analyst-blinded, randomized controlled trial.
    Lajevardi V; Ghodsi SZ; Goodarzi A; Hejazi P; Azizpour A; Beygi S
    Am J Clin Dermatol; 2015 Aug; 16(4):303-311. PubMed ID: 25786714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of mychophenolate mofetil in treating lichen planopilaris.
    Azizpour A; Hatami P; Lajevardi V; Mohammadi M; Aryanian Z; Mohandesi NA
    Dermatol Ther; 2022 Aug; 35(8):e15625. PubMed ID: 35674693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system.
    Chiang C; Sah D; Cho BK; Ochoa BE; Price VH
    J Am Acad Dermatol; 2010 Mar; 62(3):387-92. PubMed ID: 20061052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofacitinib for the treatment of lichen planopilaris: A case series.
    Yang CC; Khanna T; Sallee B; Christiano AM; Bordone LA
    Dermatol Ther; 2018 Nov; 31(6):e12656. PubMed ID: 30264512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal fibrosing alopecia: a clinical review of 36 patients.
    Samrao A; Chew AL; Price V
    Br J Dermatol; 2010 Dec; 163(6):1296-300. PubMed ID: 20698851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lichen planopilaris: update on pathogenesis and treatment.
    Baibergenova A; Donovan J
    Skinmed; 2013; 11(3):161-5. PubMed ID: 23930355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series of 46 patients with lichen planopilaris: Demographics, clinical evaluation, and treatment experience.
    Lyakhovitsky A; Amichai B; Sizopoulou C; Barzilai A
    J Dermatolog Treat; 2015 Jun; 26(3):275-9. PubMed ID: 24913130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil and lichen planopilaris: systematic review and meta-analysis.
    Mostafa N; Phan K; Smith S
    J Dermatolog Treat; 2022 Feb; 33(1):369-372. PubMed ID: 32281437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial.
    Fatemi Naeini F; Mohaghegh F; Jelvan M; Asilian A; Saber M
    Int Immunopharmacol; 2020 Sep; 86():106765. PubMed ID: 32674048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commentary: treatment of lichen planopilaris: some progress, but a long way to go.
    Sperling LC; Nguyen JV
    J Am Acad Dermatol; 2010 Mar; 62(3):398-401. PubMed ID: 20061055
    [No Abstract]   [Full Text] [Related]  

  • 13. A Systematic Review and Bayesian Network Meta-Analysis of Medical Therapies for Lichen Planopilaris.
    Husein-ElAhmed H; Husein-ElAhmed S
    Dermatology; 2024; 240(1):103-110. PubMed ID: 37852211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
    Lajevardi V; Ghiasi M; Balighi K; Daneshpazhooh M; Azar PM; Kianfar N; Dasdar S; Peymanfar AA
    Dermatol Ther; 2022 Nov; 35(11):e15868. PubMed ID: 36169160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lichen planopilaris: update on diagnosis and treatment.
    Assouly P; Reygagne P
    Semin Cutan Med Surg; 2009 Mar; 28(1):3-10. PubMed ID: 19341936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience.
    Mardones F; Shapiro J
    Clin Exp Dermatol; 2017 Oct; 42(7):755-759. PubMed ID: 28748570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients.
    Wee JS; Shirlaw PJ; Challacombe SJ; Setterfield JF
    Br J Dermatol; 2012 Jul; 167(1):36-43. PubMed ID: 22309851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris: a randomized controlled clinical trial.
    Lajevardi V; Salarvand F; Ghiasi M; Nasimi M; Taraz M
    J Dermatolog Treat; 2022 Mar; 33(2):769-773. PubMed ID: 32449418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil in erosive genital lichen planus: a case and review of the literature.
    Deen K; McMeniman E
    J Dermatol; 2015 Mar; 42(3):311-4. PubMed ID: 25583369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of lipedematous alopecia using mycophenolate mofetil.
    Cabrera R; Larrondo J; Whittle C; Castro A; Gosch M
    Acta Derm Venereol; 2015 Nov; 95(8):1011-2. PubMed ID: 25881615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.